A therapeutic application of the experience sampling method in the treatment of depression: a randomized controlled trial
A therapeutic application of the experience sampling method in the treatment of depression: a randomized controlled trial
复制标题
DOI：
10.1002/wps.20090
复制
发表时间：
2014-02-01
期刊：
影响因子：
73.3
通讯作者：
Wichers, Marieke
中科院分区：
文献类型：
--
作者：
Kramer, Ingrid;Simons, Claudia J. P.;Wichers, Marieke
在抑郁症中，体验日常生活积极影响的能力可以预测康复并降低复发率。基于经验抽样方法 (ESM-I) 的干预措施非常适合提供对个人的、情境化的积极影响模式的洞察。本研究的目的是检验附加 ESM 衍生的关于个性化积极情感模式的反馈是否可行且对患者有用，并能减少抑郁症状。接受药物治疗的抑郁症门诊患者 (n=102) 参加了一项分为三组的随机对照试验：一个接受附加 ESM 衍生反馈的实验组，一个参与 ESM 但不接收反馈的伪实验组，以及一个对照组。实验组使用掌上电脑参与 ESM 程序（在 6 周内每周三天）。该小组每周都会收到关于个性化积极影响模式的标准化反馈。干预前后获得汉密尔顿抑郁量表 - 17 (HDRS) 和抑郁症状清单 (IDS) 评分。在 6 个月的随访期内，完成了五项 HDRS 和 IDS 评估。附加 ESM 衍生反馈导致 HDRS 评分相对于对照组显着且临床相关的更强下降 (p
In depression, the ability to experience daily life positive affect predicts recovery and reduces relapse rates. Interventions based on the experience sampling method (ESM-I) are ideally suited to provide insight in personal, contextualized patterns of positive affect. The aim of this study was to examine whether add-on ESM-derived feedback on personalized patterns of positive affect is feasible and useful to patients, and results in a reduction of depressive symptomatology. Depressed outpatients (n=102) receiving pharmacological treatment participated in a randomized controlled trial with three arms: an experimental group receiving add-on ESM-derived feedback, a pseudo-experimental group participating in ESM but receiving no feedback, and a control group. The experimental group participated in an ESM procedure (three days per week over a 6-week period) using a palmtop. This group received weekly standardized feedback on personalized patterns of positive affect. Hamilton Depression Rating Scale - 17 (HDRS) and Inventory of Depressive Symptoms (IDS) scores were obtained before and after the intervention. During a 6-month follow-up period, five HDRS and IDS assessments were completed. Add-on ESM-derived feedback resulted in a significant and clinically relevant stronger decrease in HDRS score relative to the control group (p